EHA25 Virtual | News Room

EHA25VIRTUAL Image 02 1

Welcome to the news room of EHA25 Virtual where you can find the most relevant news items. Feel free to browse through the latest press releases below and make sure to keep an eye on this page for upcoming news items.

Read more

Guidelines for hematologists

AdobeStock 293330068

EHA creates clinical practice guidelines for diagnosis and treatment of hematologic diseases. View the EHA methodology for guidelines, EHA Guidelines by topic and Guidelines produced by other societies and endorsed by EHA

Read more

Recommendation for hematologists in COVID-19 crisis

Recommendations FAQ

As COVID19 progresses limited information is available in hematology to manage patient care during the pandemic. The EHA Scientific Working Group Infections in Hematology has developed key questions and answers to stand by hematology professionals in the COVID19 crisis.

Read more

EHA statement on coronavirus (COVID-19)

AdobeStock 320164385 homepage

The European Hematology Association (EHA) closely monitors the latest developments on the spreading of the Coronavirus (COVID-19).

Read more

ATMPs and CAR-T: the uptake challenge

HemAffairs ATMPs and CAR T

Advanced therapy medicinal products (ATMPs) are a game changer for improving the lives of patients with severe to life-threatening diseases. Yet, despite fast-paced innovation in the field, few ATMPs have reached the EU market and benefited patients. The challenges facing their adoption by health systems are complex. A test case is the uptake of CAR T-cell therapy; what are the hurdles and what action is needed from stakeholders?

Read more

EU health policy: limited scope, high ambition

HemAffairs EU health policy

While health policy remains the primary responsibility of Member States, in many areas the added value of EU-level collaboration and harmonization has increased. EU initiatives in health have shown a mixed record in terms of impact, but hopes are high for the latest one, the ambitious Europe’s Beating Cancer Plan.

Read more

Meet Helen Papadaki, our January volunteer of the month

Helen Papadaki website

I am currently a Councilor of the EHA Board for the period 2016-2020, chair of the EHA Membership Committee and vice-chair of the Scientific Working Group (SWG) on Granulocytes &...

Read more

Meet Michaela Gruber, our December volunteer of the month

Michaela Gruber website
Dr Michaela Gruber was one of the initiators of YoungEHA as well as a founding member of the YoungEHA Committee. Meet Michaela Gruber and learn about what she does and why she has been volunteering for EHA for all these years.
Read more

Revising the ICH Guidelines on Clinical Trials

Delegation HemAffairs

Clinical trials and drug development have become more complex over the years. One complicating factor is the increased administrative burden, as was pointed out in the previous edition of HemAffairs. Doctors and clinical researchers are more and more bound to rules they deem neither necessary nor effective. At first sight, the requirements for clinical trials seem clear and thorough. Nonetheless, the interpretation and implementation of these rules leave room for improvement.

Read more

The past and future of the EU Blood, Tissues and Cells legislation

Annake HemAffairs HR

Blood, tissues and cells (BTC) are used in medicine and in hematology on a daily basis. EU legislation has been in place for over 15 years to regulate those practices, and to ensure safety and quality standards for substances of human origin (SoHO). For instance, through technical and traceability requirements for BTC, the reporting of serious adverse reactions (SARs), and verification procedures for imported BTC.

Read more

EHA at ICH meeting: Excessive bureaucracy harms patient safety and innovation

EHA delegation to ICH public meeting

To solicit input from a wide range of non-ICH members about the revision of ICH E8(R1), ICH held a Public Meeting on ICH E8(R1) “General Considerations for Clinical Studies” (Silver Spring, USA, October 31, 2019).

Read more

Meet Stefan Fröhling, our November volunteer of the month

Voulenteer of the month 2
Professor Stefan Fröhling was first introduced to EHA in 2002 when he attended the 7th EHA Congress in Florence. He has served in a number of committees and has been an EHA Board Member (2013-2017). Currently, Professor Fröhling is a member of the EHA Scientific Working Group Unit and an Associate Editor of HemaSphere, the official journal of EHA.
Meet Stefan Fröhling and learn about what he does and why he has been volunteering for EHA for all these years.
Read more

EHA returns to Cairo with the Highlights of the 24th EHA Congress

Cairo group photo HOPE MENA 2019

The 4th Highlights of Past EHA (HOPE) Middle East & North Africa (MENA) took place (for the third time) in Cairo, Egypt, organized in collaboration with the Pan Arab Hematology Association (PAHA) and hosted by the Egyptian Society of Hematology and Research (ESHR), and supported by the national hematology societies from the region, who were represented in the program as chairs of various sessions.

Read more

EHA’s Prof Jäger elected HCPWP co-chair

HCPWP co chairs Prof. Ulrich Jaeger EHA and Juan Garcia Burgos EMA

On September 24, Prof Ulrich Jäger, former EHA President and current member of the EHA European Affairs Committee, was elected as co-chair of the Health Care Professionals Working Party (HCPWP) of the European Medicines Agency (EMA). He will lead the working party during its 2019-2022 mandate alongside Juan Garcia-Burgos, EMA’s head of Public Engagement.

Read more

EHA24, another successful congress

More than 12,000 hematology professionals from around the world met together in Amsterdam, The Netherlands for the 24th European Hematology Association (EHA) Congress.

Read more